ANDA 76570, held by Sun Pharmaceutical Industries. Trimethobenzamide Hydrochloride.
As of Nov 21, 2026, ANDA 76570 (Trimethobenzamide Hydrochloride), held by Sun Pharmaceutical Industries, was first approved by FDA on Aug 28, 2003, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 28, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trimethobenzamide Hydrochloride300MG · capsule;oral | Trimethobenzamide Hydrochloride | Discontinued |
| Apr 22, 2020 | Supplement 18Labeling · Standard review | Approved | None posted |
| Oct 29, 2010 | Supplement 11Labeling | Approved | None posted |
| Jun 18, 2008 | Supplement 9Labeling | Approved | None posted |
| Aug 28, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters